中商官网
研究报告
三生制药（HK1530）
| 科目\年度 | 2025-06-30 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
原始货币 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 审计意见 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 报表核心指标 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 税后利润 |
138857.40 | 221754.90 | 158629.20 | 190885.90 | 162757.30 | 77110.59 | 98022.80 | 127724.60 | 92440.39 | 71425.40 | 52623.00 | 29172.80 | 9605.90 | 10188.70 |
| 营业收入 |
435548.50 | 910797.80 | 781593.80 | 686573.50 | 638200.90 | 558763.60 | 531809.10 | 458386.90 | 373433.40 | 279728.90 | 167312.60 | 113085.40 | 87539.59 | 65614.50 |
| 销售成本 |
63968.00 | 127960.20 | 117429.80 | 119416.10 | 110628.60 | 106291.10 | 92534.70 | 87725.49 | 67623.50 | 40226.80 | 24191.10 | 8748.10 | 8317.90 | 7050.40 |
| 税前利润 |
162169.70 | 271808.50 | 197845.90 | 227959.60 | 186876.60 | 97912.90 | 122301.30 | 149551.10 | 110201.70 | 85006.80 | 58785.60 | 36018.40 | 20870.80 | 13040.60 |
| 归属于母公司股东利润 |
135820.40 | 209032.00 | 154923.90 | 191572.70 | 165124.70 | 83579.09 | 97371.70 | 127716.70 | 93538.90 | 71256.40 | 52628.00 | 29172.80 | 9589.20 | 10166.60 |
| 营业收入 |
435548.50 | 910797.80 | 781593.80 | 686573.50 | 638200.90 | 558763.60 | 531809.10 | 458386.90 | 373433.40 | 279728.90 | 167312.60 | 113085.40 | 87539.59 | 65614.50 |
| 其中：营业额 |
435548.50 | 910797.80 | 781593.80 | 686573.50 | 638200.90 | 558763.60 | 531809.10 | 458386.90 | 373433.40 | 279728.90 | 167312.60 | 113085.40 | 87539.59 | 65614.50 |
| 销售成本 |
63968.00 | 127960.20 | 117429.80 | 119416.10 | 110628.60 | 106291.10 | 92534.70 | 87725.49 | 67623.50 | 40226.80 | 24191.10 | 8748.10 | 8317.90 | 7050.40 |
| 毛利 |
371580.50 | 782837.60 | 664164.00 | 567157.40 | 527572.30 | 452472.50 | 439274.40 | 370661.40 | 305809.90 | 239502.10 | 143121.50 | 104337.30 | 79221.70 | 58564.10 |
| 加：其他收入 |
40828.90 | 470.10 | 30506.20 | 74991.70 | 33006.90 | 17817.10 | 21810.70 | 42981.00 | 19579.30 | 21559.40 | 20861.80 | 4776.30 | 2415.90 | 2841.60 |
| 减：销售费用 |
161593.40 | 335134.90 | 300622.50 | 258052.80 | 232401.70 | 201971.70 | 195073.30 | 169116.70 | 133270.30 | 101719.60 | 58558.50 | 43143.20 | 34064.30 | 30441.90 |
| 管理费用 |
83092.50 | 182847.80 | 127561.90 | 108724.40 | 112536.00 | 104311.90 | 120257.40 | 67945.70 | 31510.50 | 30123.60 | 30104.40 | 17077.00 | 15920.70 | 8209.10 |
| 财务费用 |
5300.20 | 19084.60 | 21229.60 | 10274.80 | 6652.50 | 8106.60 | 10947.60 | 13838.20 | 14135.00 | 14771.00 | 2654.50 | 2918.20 | -- | -- |
| 其他费用 |
2546.60 | 9325.10 | 44430.80 | 33712.80 | 18402.30 | 54947.20 | 11402.40 | 12366.20 | 34827.50 | 28222.30 | 14265.10 | 9818.50 | 10324.20 | 9697.60 |
| 经营溢利 |
159876.70 | 236915.30 | 200825.40 | 231384.30 | 190586.70 | 100952.20 | 123404.40 | 150375.60 | 111645.90 | 86225.00 | 58400.80 | 36156.70 | 21328.40 | 13057.10 |
| 加：应占联营公司业绩 |
2161.50 | 35056.00 | -3084.80 | -3169.20 | -3392.30 | -2986.80 | -1600.10 | -824.50 | -1444.20 | -1218.20 | 384.80 | -138.30 | -457.60 | -16.50 |
| 应占共同控制实体业绩 |
131.50 | -162.80 | 105.30 | -255.50 | -317.80 | -52.50 | 497.00 | -- | -- | -- | -- | -- | -- | -- |
| 税前利润 |
162169.70 | 271808.50 | 197845.90 | 227959.60 | 186876.60 | 97912.90 | 122301.30 | 149551.10 | 110201.70 | 85006.80 | 58785.60 | 36018.40 | 20870.80 | 13040.60 |
| 减：所得税费用 |
23312.30 | 50053.60 | 39216.70 | 37073.70 | 24119.30 | 20802.30 | 24278.50 | 21826.50 | 17761.30 | 13581.40 | 6162.60 | 6845.60 | 11264.90 | 2851.90 |
| 税后利润 |
138857.40 | 221754.90 | 158629.20 | 190885.90 | 162757.30 | 77110.59 | 98022.80 | 127724.60 | 92440.39 | 71425.40 | 52623.00 | 29172.80 | 9605.90 | 10188.70 |
| 归属于母公司股东利润 |
135820.40 | 209032.00 | 154923.90 | 191572.70 | 165124.70 | 83579.09 | 97371.70 | 127716.70 | 93538.90 | 71256.40 | 52628.00 | 29172.80 | 9589.20 | 10166.60 |
| 归属于非控制股股东利润 |
3037.00 | 12722.90 | 3705.30 | -686.80 | -2367.40 | -6468.50 | 651.10 | 7.90 | -1098.50 | 169.00 | -5.00 | -- | 16.70 | 22.10 |
| 基本每股收益 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- | -- |
| 稀释每股收益 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- | -- |
| 其他综合收益 |
-1414.40 | 6765.60 | -10132.70 | -6210.70 | 4153.20 | 7326.30 | 2859.10 | 10388.50 | -12934.60 | 19095.10 | 13006.90 | -793.40 | -70.90 | 852.60 |
| 综合收益总额 |
137443.00 | 228520.50 | 148496.50 | 184675.20 | 166910.50 | 84436.90 | 100881.90 | 138113.10 | 79505.80 | 90520.50 | 65629.90 | 28379.40 | 9535.00 | 11041.30 |
| 归属于母公司股东综合收益总额 |
134406.00 | 215797.60 | 144791.20 | 185362.00 | 169277.90 | 90905.40 | 100230.80 | 138105.20 | 80604.30 | 90351.50 | 65634.90 | 28379.40 | 9518.30 | 11019.20 |
| 归属于非控制股股东综合收益总额 |
3037.00 | 12722.90 | 3705.30 | -686.80 | -2367.40 | -6468.50 | 651.10 | 7.90 | -1098.50 | 169.00 | -5.00 | -- | 16.70 | 22.10 |